ME Therapeutics updates in vivo CAR and therapeutic mRNA STING programs
ME Therapeutics said it is providing a comprehensive update on its in vivo CD19/CD22 CAR program and its therapeutic mRNA STING program efforts.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.